Oxurion NV Expands Capital for Innovative Eye Care

Oxurion NV (GB:0G99) has released an update.

Don't Miss Our New Year's Offers:

Oxurion NV has increased its capital by EUR 150,000 following the conversion of six convertible bonds by Atlas Special Opportunities, LLC, boosting the total number of shares to over 3.1 million. This capital increase is part of a larger EUR 20 million commitment aimed at advancing innovative eye care solutions for the elderly. The move positions Oxurion to tap into a market potential valued between USD 3-6 billion.

For further insights into GB:0G99 stock, check out TipRanks’ Stock Analysis page.

Trending Articles

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.